Volume 21, Number 8—August 2015
Research
Development of Framework for Assessing Influenza Virus Pandemic Risk
Susan C. Trock
, Stephen A. Burke, and Nancy J. Cox
, Stephen A. Burke, and Nancy J. Cox
Table 4
Average risk point scores and ranked weighting applied to risk scoring of influenza A(H7N9) virus isolate A/Shanghai/1/2013 for emergence and impact questions, April 2013 and May 2013*
| Emergence question |
Impact question |
|||||||
|---|---|---|---|---|---|---|---|---|
| Element | Weight | Average point scores |
Element | Weight | Average point scores |
|||
| Apr 2013 | May 2013 | Apr 2013 | May 2013 | |||||
| Human infections | 0.2929 | 5.0 | 5.0 | Disease severity | 0.2929 | 9.0 | 8.5 | |
| Transmission (laboratory animals) | 0.1929 | 1.0 | 7.0 | Population immunity | 0.1929 | 9.0 | 9.0 | |
| Receptor binding | 0.1429 | 6.7 | 6.3 | Human infections | 0.1429 | 5.0 | 5.0 | |
| Population immunity | 0.1096 | 9.0 | 9.0 | Antivirals/treatment options | 0.1096 | 5.4 | 5.8 | |
| Infections in animals | 0.0846 | 6.0 | 4.7 | Antigenic relationship | 0.0846 | 6.0 | 3.7 | |
| Genomic variation | 0.0646 | 8.6 | 8.6 | Receptor binding | 0.0646 | 6.7 | 6.3 | |
| Antigenic relationship | 0.0479 | 6.0 | 3.7 | Genomic variation | 0.0479 | 8.6 | 8.6 | |
| Global distribution (animals) | 0.0336 | 1.0 | 4.7 | Transmission (laboratory animals) | 0.0336 | 1.0 | 7.0 | |
| Disease severity | 0.0211 | 9.0 | 8.5 | Global distribution (animals) | 0.0211 | 1.0 | 4.7 | |
| Antivirals/treatment options | 0.001 | 5.4 | 5.8 | Infections in animals | 0.001 | 6.0 | 4.7 | |
| Weighted IRAT aggregate score | 5.2 | 6.2 | Weighted IRAT aggregate score | 7.1 | 7.0 | |||
*IRAT, Influenza Risk Assessment Tool.
Page created: July 14, 2015
Page updated: July 14, 2015
Page reviewed: July 14, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.